Karyopharm Therapeutics: Q2 Earnings Snapshot
By AP News
Published - Aug 06, 2024, 10:59 AM ET
Last Updated - Aug 06, 2024, 10:59 AM EDT
NEWTON, Mass. (AP) — NEWTON, Mass. (AP) — Karyopharm Therapeutics Inc. (KPTI) on Tuesday reported second-quarter earnings of $23.8 million.
On a per-share basis, the Newton, Massachusetts-based company said it had net loss of 20 cents.
The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 29 cents per share.
The pharmaceutical company posted revenue of $42.8 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $36.1 million.
